Lactate Dehydrogenase Reagents Market Size & Share, by Type (LDH Cytotoxicity Colorimetric Assay, LDH Cytotoxicity Fluorometric Assay, SRB Assay, WST Assay); End User - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Lactate Dehydrogenase Reagents Industry - Regional Synopsis

North America Market Analysis

North America is a key player in the lactate dehydrogenase reagents market, projected to register a notable share of 42.4% in 2037. The dominance of the region is attributable to the advanced medical infrastructure with exceptional laboratories and diagnostic provisions, with high adoption of LDH reagents. For instance, in November 2024, Augurex Life Sciences Corp., in collaboration with New Day Diagnostics, launched Anti-14-3-3eta multiplex analyte-specific reagents, offering diagnostic tests for axial spondyloarthritis. These collaborations, coupled with increased launch activities, are augmenting the region’s growth for reagents such as LDH during the forecast period.

U.S. dominates the North America lactate dehydrogenase reagents market owing to early adoption of cutting-edge LDH assays diagnostic technologies, due to the rising occurrence of chronic diseases such as cancer and cardiovascular diseases.  In April 2024, Sysmex Corporation with  Siemens Healthcare Diagnostics Inc., declared that it had begun selling hemostasis instruments and reagents under the Sysmex brand in the U.S. and EU. This move is part of a mutual OEM supply agreement with Siemens Healthineers signed in February 2023. Such milestones help independently distribute their reagent solutions and expand their global reach, thereby uplifting market growth.

The Canada lactate dehydrogenase reagents market is growing steadily with several collaborative approaches, including public-private partnerships, marketing approvals, and ensuring a robust diagnostic adoption across key sectors. For instance, in April 2025, Augurex Life Sciences Corp. notified that it received Health Canada clearance for SPINEstat, a Class II medical device, which is a diagnostic blood test prescribed for axial spondyloarthritis, an autoimmune condition impacting the spine. Hence, it highlights the growing need for reagents in the diagnostic market, thereby strengthening their ecosystems and positioning Canada as global leader in the market.

APAC Market Statistics

The Asia Pacific lactate dehydrogenase reagents market is anticipated to grow at the fastest rate during the forecast period. The market is immensely supported by the rising occurrence of chronic diseases, which inspires the population to leverage early diagnosis and management procedures utilizing the lactase dehydrogenase reagents. Moreover, the region hosts a large consumer base that is the geriatric population, demanding accurate diagnostic reagents. The robust medical infrastructure also supports market upliftment, positioning Asia Pacific as the global leader in the LDH reagents market.

China is a leader in the lactate dehydrogenase reagents market, supported by the population and healthcare providers due to an awareness of early disease diagnosis. The rising healthcare investments are pushing the domestic players to launch more of such reagents that are crucial for different sorts of diagnostic and therapeutic applications. In September 2021, Medical and Biological Laboratories Co., Ltd. notified that it’s that its subsidiary MBL Shenzhen Biotech Co., Ltd. had entrenched an exclusive research and development manufacturing hub for in vitro diagnostic products and services in China. As a global hub for innovation and manufacturing, the country’s market continues to expand rapidly, shaping the region’s diagnostic landscape.

Indias lactate dehydrogenase reagents market is gaining momentum, fueled by the enhanced medical infrastructure, facilitating proper diagnosis and disease monitoring with a wider adoption of lactate dehydrogenase reagents. Moreover, the country’s focus on innovative detection tests is inspiring domestic players to launch more of such tests. In March 2022, Mylab Discovery Solutions announced its plans to launch a wide range of diagnostic kits, including reagents for various disorders and devices in both conventional and POCT formats, accounting for biochemistry, immunology, and hematology, expanding the existing self-test offerings. This denotes a positive outlook, making India a rapidly emerging player in the global lactate dehydrogenase reagents market.